Actemra 80 mg Injection

Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints, and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Actemra 80 mg helps reduce inflammation and manage the symptoms of Rheumatoid arthritis.

Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Actemra Injection works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Actemra 80 mg Injection can help relieve pain, stiffness, and other symptoms of the condition.

Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhoea, weight loss, fatigue, and loss of appetite. Actemra 80 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Actemra 80 mg Injection can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhoea, and inflammation.

Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Actemra Injection can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.

Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Actemra 80 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Actemra 80 mg Injection can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.

Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Actemra 80 mg Injection works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of Juvenile idiopathic arthritis, including pain, stiffness, and swelling. Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Actemra Injection reduces the scaly, itchy patches which may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness, and can affect any joint in the body. Actemra 80 mg Injection works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.

Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Actemra 80 mg is a tumour necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.